Understanding Idepinone Dosing and Accessibility for LHON Patients

This chapter focuses on the dosing regimen of Idepinone for treating Leber Hereditary Optic Neuropathy, typically 300 mg taken three times daily with meals. It also addresses the drug's unapproval status in the U.S., accessibility challenges, and the financial burden on patients, emphasizing safety despite high costs.